8872
W.-R. Li et al. / Tetrahedron 56 (2000) 8867±8875
General procedure for the synthesis of dipeptides such as
Z-alaninylisoleucine ethyl ester
(m, 1H), 4.60±4.67 (m, 1H), 6.61 (br d, 1H J7.4 Hz), 7.02
(br d, 1H, J8.4 Hz); 13C NMR (CDCl3/TMS) d 11.56,
14.14, 15.41, 18.49, 23.00, 25.00, 37.58, 48.70, 56.63,
61.14, 169.91, 171.53, 172.40; HRMS Calcd for
C13H24N2O4 (M1) 272.1736, found 272.1755.
Isoleucine (1.17 g, 8.93 mmol) was dissolved in EtOH
(40 mL) in a ¯ame-dried ¯ask equipped with a magnetic
stirrer. To this stirred solution was added dropwise, under
argon, a solution of thionyl chloride in EtOH (5 mL, 7 M).
The reaction mixture was re¯uxed for 6 h, and then concen-
trated under reduced pressure. The resulting crude material
was dissolved in CH2Cl2 (30 mL). To this solution was
added triethylamine (1.8 mL, 13.39 mmol) at 08C. The
reaction was stirred for 15 min. and Z-alanine (1.99 g,
8.93 mmol) in CH2Cl2 (20 mL) was added via a cannula.
1,3-Diisopropylcarbodiimide (DIC) (1.53 mL, 9.82 mmol)
was then added with stirring. After 24 h, the reaction
mixture was concentrated, and the resulting solid was
washed with cold EtOAc. The ®ltrate was concentrated
under reduced pressure and diluted with ether (250 mL).
The ether layer was washed with 10% HCl (40 mL), 5%
NaHCO3 (40 mL), and saturated NaCl (40 mL) solutions.
The organic layer was dried (Na2SO4), ®ltered, and concen-
trated. The resulting crude oil was puri®ed by column
chromatography eluting with EtOAc/hexane (40:60).
Z-alaninylisoleucine methyl ester (2.3 g, 92%) was obtained
as a white solid.
Ac-l-Phe-l-Leu-OMe (5). Mp 126±1288C; [a]2D5218.28
(c 4.0, MeOH); IR (CHCl3): n3285, 3077, 2963, 1744,
;
1657, 1549, 1200, 1153 cm21 1H NMR (200 MHz,
CDCl3) d 0.88 (d, 6H, J5.5 Hz), 1.46±1.59 (m, 3H),
1.96 (s, 3H), 3.06 (d, 2H, J6.9 Hz), 3.69 (s, 3H), 4.48±
4.55 (m, 1H), 4.60±4.81 (m, 1H), 6.34±6.43 (m, 2H), 7.23±
7.25 (m, 5H); 13C NMR (CDCl3/TMS) d 21.87, 22.63,
23.08, 24.72, 38.28, 41.34, 50.90, 52.22, 54.30, 126.95,
128.56, 129.31, 136.42, 169.95, 170.71, 172.62; HRMS
Calcd for C18H26N2O4 (M1) 334.1893, found 334.1895.
Bz-l-Ala-OMe (6). Mp 52±538C; [a]2D5138.68 (c 2.9,
CHCl3); IR (CHCl3): n3318, 2988, 1744, 1643, 1543,
1
1454 cm21; H NMR (200 MHz, CDCl3) d 1.52 (d, 3H,
J7.2 Hz), 3.78 (s, 3H), 4.71±4.91 (m, 1H), 6.83 (br d,
1H, J5.5 Hz), 7.39±7.51 (m, 3H), 7.78±7.83 (m, 2H);
13C NMR (CDCl3/TMS) d 18.56, 48.41, 52.52, 126.99,
128.51, 131.67, 133.82, 166.76, 173.65; HRMS Calcd for
C11H13NO3 (M1) 207.0895, found 207.0898.
Bz-l-Leu-OMe (7). Mp 102.5±103.58C, lit.34 103±1048C;
[a]D25222.78 (c 6.25, EtOH), lit.34 [a]2D52228 (c 3.6,
EtOH); IR (CHCl3): n3285, 3069, 2955, 1751, 1637,
Spectral data
Ac-l-Phe-OMe (1). Mp 88±898C, lit.30 87±88.58C;
[a]D251101.28 (c 2.4, CHCl3), lit.30 [a]2D51105.38 (c 1,
CHCl3), lit.31 [a]D25196.48 (c 1, CHCl3); IR (CHCl3):
1
1541, 1228, 1163 cm21; H NMR (200 MHz, CDCl3) d
0.96±1.01 (m, 6H), 1.62±1.81 (m, 3H), 3.78 (s, 3H),
4.84±4.88 (m, 1H), 6.55 (br d, 1H, J7.3 Hz), 7.40±7.52
(m, 3H), 7.78±7.83 (m, 2H); 13C NMR (CDCl3/TMS) d
22.00, 22.79, 24.93, 41.80, 51.06, 52.34, 127.01, 128.52,
131.68, 133. 86, 167.05, 173.69; HRMS Calcd for
C14H19NO3 (M1) 249.1365, found 249.1364.
n3331, 3036, 2963, 1784, 1651, 1535, 1221 cm21; H
1
NMR (200 MHz, CDCl3) d 1.98 (s, 3H), 3.09±3.14 (m,
2H), 3.72 (s, 3H), 4.88 (m, 1H), 5.95 (br d, 1H, J
6.0 Hz), 7.06±7.11 (m, 2H), 7.23±7.34 (m, 3H)32; 13C
NMR (CDCl3/TMS) d 23.11, 37.79, 52.30, 53.06, 127.10,
128.55, 129.19, 135.77, 169.57, 172.06; HRMS Calcd for
C12H15NO3 (M1) 221.1052, found 221.1036.
Bz-l-Pro-OMe (8). Mp 90±918C, lit.35 89±918C;
[a]D25299.38 (c 5.85, MeOH), lit.35 [a]2D52100.18 (c
1.17, MeOH); IR (CHCl3): n2951, 2878, 1742, 1624,
Ac-l-Met-OBn (2). [a]2D5225.78 (c 1.7, MeOH); IR
(CHCl3): n3285, 3063, 2920, 1744, 1655, 1541,
1
1572, 1448 cm21; H NMR (200 MHz, CDCl3) d 1.81±
1
1211 cm21; H NMR (200 MHz, CDCl3) d 1.88±2.17 (m,
2.34 (m, 4H), 3.50±3.71 (m, 2H), 3.77 (s, 3H), 4.36±4.68
(m, 1H), 7.36±7.59 (m, 5H)36; 13C NMR (CDCl3/TMS) d
25.33, 29.34, 49.87, 52.20, 59.08, 126.46, 127.24, 128.18,
129.72, 130.13, 136.13, 169.62, 172.72; HRMS Calcd for
C13H15NO3 (M1) 233.1052, found 233.1063.
8H), 2.41±2.50 (m, 2H), 4.70±4.81 (m, 1H), 5.18 (d, 2H,
J1.9 Hz), 6.27 (br d, 1H, J7.4 Hz), 7.32±7.45 (m, 5H);
13C NMR (CDCl3/TMS) d 15.44, 23.16, 29.83, 31.73,
51.68, 67.36, 128.34, 128.56, 128.64, 135.11, 169.84,
171.90; HRMS Calcd for C14H19NO3S (M1) 281.1086,
found 281.1079.
Bz-l-Phe-l-Leu-OMe (9). Mp 144±1478C, lit.37 163±
1668C; [a]2D5245.98 (c 4.35, MeOH); IR (CHCl3):
n3291, 3067, 2957, 1751, 1637, 1543, 1489, 1207 cm21
;
Ac-l-Ser(OAc)-OMe (3). Mp 55±568C; [a]2D5168.48 (c
4.85, CHCl3); IR (CHCl3): n 3299, 3063, 2949, 1744,
1H NMR (200 MHz, CDCl3) d 0.77 (d, 6H, J5.14 Hz),
1.35±1.55 (m, 3H), 3.12 (m, 2H), 3.64 (s, 3H), 4.43±4.52
(m, 1H), 4.84±5.00 (m, 1H), 6.50 (br d, 1H, J7.5 Hz), 6.64
(br d, 1H, J8.8 Hz), 7.01±7.66 (m, 10H); 13C NMR
(CDCl3/TMS) d 21.84, 22.62, 24.72, 38.30, 41.29, 50.98,
52.28, 54.59, 127.02, 128.64, 129.45, 131.82, 133.71,
136.43, 167.20, 170.66, 172.66; HRMS Calcd for
C23H28N2O4 (M1) 396.2049, found 396.2057.
1657, 1543, 1375, 1227 cm21
;
1H NMR (200 MHz,
CDCl3) d 2.05 (s, 6H), 3.78 (s, 3H), 4.30±4.51 (m, 2H),
4.82±4.90 (m, 1H), 6.25 (br d, 1H, J6.0 Hz)33; 13C NMR
(CDCl3/TMS) d 20.47, 22. 79, 51.56, 52.66, 63.74, 169.97,
170.46; HRMS Calcd for C8H13NO5 (M1) 203.0794, found
203.0784.
Ac-l-Ala-l-Ile-OEt (4). Mp 103±1068C; [a]2D5219.38 (c
4.75, CHCl3); IR (CHCl3): n3285, 2963, 1744, 1643,
Resin-bound phenylalanine lithium salt (11).20,38 The
hydroxymethyl resin39 (300 mg, 0.48 mmol) was suspended
in dry CH2Cl2 (1.9 mL) and treated with p-nitrophenyl
chloroformate (290.3 mg, 1.44 mmol) and DIPEA
1543, 1448, 1259, 1024 cm21
;
1H NMR (200 MHz,
CDCl3) d 0.85±0.92 (m, 6H), 1.18±1.41 (m, 8H), 1.87±
1.97 (m, 1H), 1.99 (s, 3H), 4.12±4.24 (m, 2H), 4.45±4.53